×
About 5,905 results

ALLMedicine™ Hyperthermia Center

Research & Reviews  2,202 results

Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic R...
https://doi.org/10.1007/s12640-021-00416-z 10.1542/peds.106.1.158 10.1152/jappl.1992.72.6.2099 10.1081/JA-200066866 10.1111/j.1360-0443.2006.01423.x 10.1111/j.1476-5381.2009.00186.x 10.1056/NEJMra011089 10.1080/10826080500411528 10.1001/jama.1987.03400060056021 10.1111/j.0953-816X.2004.03453.x 10.1016/j.forsciint.2019.03.047 10.1017/S1049023X17007099 10.1016/j.brainres.2006.06.087 10.2215/CJN.02080508 10.1152/physrev.00015.2003 10.1016/j.ejphar.2007.06.006 10.1016/j.alcohol.2004.09.003 10.1038/sj.npp.1300714 10.1038/s41598-021-85389-x 10.1007/s002130050908 10.1038/sj.bjp.0701859 10.1007/s002130100762 10.1038/sj.bjp.0702373 10.1016/S0163-7258(03)00003-2 10.2165/00007256-200434010-00002 10.1007/BF02249342 10.1016/0031-9384(95)00136-7 10.4161/23328940.2014.985953 10.1002/(SICI)1099-1077(199705/06)12:3<221::AID-HUP854>3.0.CO;2-C 10.1016/S0006-8993(00)02308-8 10.1097/00007691-200404000-00009 10.1159/000253553 10.1007/BF02376775 10.1111/j.1476-5381.2010.00722.x 10.1001/jama.1987.03390120077027 10.1177/0269881108100020 10.1177/0269881106063271 10.1152/ajpregu.1982.242.5.R522 10.1111/j.1749-6632.2002.tb04181.x 10.1211/0022357011777855 10.1007/s00213-005-0149-6 10.1139/h99-016 10.1016/j.jemermed.2009.05.001 10.7326/0003-4819-73-1-81 10.1016/0091-3057(91)90288-D 10.1007/s00421-019-04283-7 10.1301/nr.2003.aug.261-271 10.1016/j.ejphar.2004.07.006 10.1007/s00213-003-1725-2 10.1017/S1481803500012598 10.1093/bja/ael078 10.1007/s00213-007-0752-9 10.1016/j.pbb.2006.04.023 10.1007/s00213-007-1007-5 10.1093/qjmed/95.7.431 10.1136/bmj.305.6844.5 10.1016/S0140-6736(05)78744-4 10.1016/0140-6736(92)91469-O 10.1007/s00213-004-2030-4 10.1136/emermed-2012-202174 10.1016/S0741-8329(97)00136-5 10.1111/j.1476-5381.2012.01936.x 10.1007/s00213-006-0602-1 10.1016/0163-7258(83)90018-9 10.1016/j.drugalcdep.2009.05.016 10.1016/j.drugalcdep.2008.04.001 10.1111/j.1465-3362.2011.00348.x 10.1093/brain/awq103 10.1523/JNEUROSCI.0506-14.2014 10.1038/npp.2015.182 10.1111/j.1748-1716.1992.tb09276.x 10.4161/23328940.2014.955433 10.1007/s002130000648 10.1523/JNEUROSCI.18-13-05086.1998 10.1038/426403a 10.1007/s00109-004-0591-7 10.1016/j.pbb.2011.06.032 10.1152/jappl.1992.73.4.1340 10.1111/j.1360-0443.2011.03399.x 10.1016/j.drugpo.2019.07.005 10.1080/17425255.2020.1749262 10.1016/j.drugalcdep.2011.08.012 10.1002/hup.773 10.1016/j.jemermed.2005.05.007 10.1523/JNEUROSCI.21-21-08648.2001 10.1001/archinte.1963.03860020052002 10.1007/s00213-011-2598-4 10.1097/00003246-198611000-00011 10.1172/JCI103092 10.1016/j.neuroscience.2008.04.041 10.1124/jpet.104.079236 10.1007/s00213-004-2106-1 10.1177/026988110401800312 10.1152/jappl.1985.59.5.1394 10.1007/s00213-003-1730-5 10.1002/hup.528 10.1097/EJA.0b013e32835a1127 10.1172/JCI105900 10.1177/0269881121991792 10.1152/jappl.1997.83.4.1152 10.1038/sj.bjp.0705823 10.1097/01.CCM.0000165969.29002.70 10.1016/B978-0-444-64074-1.00036-7 10.1097/00063110-199909000-00014 10.1007/s00213-014-3759-z 10.1111/j.1365-2044.1993.tb07072.x 10.1016/S0376-8716(99)00002-2 10.1177/0269881119897559 10.1093/ndt/gft023 10.1007/s00213-010-1864-1 10.1111/j.1476-5381.2012.02065.x 10.1080/10408444.2020.1867822 10.1136/emj.15.5.322 10.1016/S0376-8716(00)00215-5 10.1074/jbc.272.52.32847
Neurotoxicity Research; van Amsterdam J, Brunt TM et. al.

Sep 24th, 2021 - Although MDMA (ecstasy) is a relatively safe recreational drug and is currently considered for therapeutic use for the treatment of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD), recreational MDMA use occasionally elicits hyp...

Drug Development of Lyso-thermosensitive Liposomal Doxorubicin: Combining Hyperthermia ...
https://doi.org/10.1016/j.addr.2021.113985
Advanced Drug Delivery Reviews; Borys N, Dewhirst MW

Sep 24th, 2021 - We review the drug development of lyso-thermosensitive liposomal doxorubicin (LTLD) which is the first heat-activated formulation of a liposomal drug carrier to be utilized in human clinical trials. This class of compounds is designed to carry a p...

Risk factors for hyperthermia mortality among emergency department patients.
https://doi.org/10.1016/j.annepidem.2021.09.009
Annals of Epidemiology; Hall C, Ha S et. al.

Sep 22nd, 2021 - This study examines risk factors for heat-related mortality due to hyperthermia in emergency department patients, a vulnerable population. This matched case-control study used statewide, longitudinally linked emergency department (ED) data and dea...

Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photot...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454134
Journal of Nanobiotechnology; Shan X, Zhang X et. al.

Sep 22nd, 2021 - Photothermal therapy (PTT) has been extensively investigated as a tumor-localizing therapeutic modality for neoplastic disorders. However, the hyperthermia effect of PTT is greatly restricted by the thermoresistance of tumor cells. Particularly, t...

A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447513
Acta Neuropathologica Communications; Biancalana V, Rendu J et. al.

Sep 19th, 2021 - The ryanodine receptor RyR1 is the main sarcoplasmic reticulum Ca2+ channel in skeletal muscle and acts as a connecting link between electrical stimulation and Ca2+-dependent muscle contraction. Abnormal RyR1 activity compromises normal muscle fun...

see more →

Guidelines  4 results

Consensus guidelines on perioperative management of malignant hyperthermia suspected or...
https://doi.org/10.1016/j.bja.2020.09.029
British Journal of Anaesthesia; Rüffert H, Bastian B et. al.

Nov 3rd, 2020 - Malignant hyperthermia is a potentially fatal condition, in which genetically predisposed individuals develop a hypermetabolic reaction to potent inhalation anaesthetics or succinylcholine. Because of the rarity of malignant hyperthermia and ethic...

Availability of dantrolene for the management of malignant hyperthermia crises: Europea...
https://doi.org/10.1016/j.bja.2020.04.089
British Journal of Anaesthesia; Glahn KPE, Bendixen D et. al.

Jun 28th, 2020 - Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is essential to achieve the best possible outcome for the patient. However, malignant hyperthermia crises are rare, and there may be administrative pressures...

Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society...
https://doi.org/10.1213/ANE.0000000000004257
Anesthesia and Analgesia; Urman RD, Rajan N et. al.

Jun 6th, 2019 - This document represents a joint effort of the Society for Ambulatory Anesthesia (SAMBA) and the Ambulatory Surgical Care Committee of the American Society of Anesthesiologists (ASA) concerning the safe anesthetic care of adult malignant hyperther...

Special article: Creation of a guide for the transfer of care of the malignant hyperthe...
https://doi.org/10.1213/ANE.0b013e3182373b4a
Anesthesia and Analgesia; Larach MG, Dirksen SJ et. al.

Nov 5th, 2011 - Volatile anesthetics and/or succinylcholine may trigger a potentially lethal malignant hyperthermia (MH) event requiring critical care crisis management. If the MH triggering anesthetic is given in an ambulatory surgical center (ASC), then the pat...

see more →

Drugs  85 results see all →

News  71 results

The Child in Shock: Assessment and Treatment
https://www.medscape.com/viewarticle/953208

Jul 14th, 2021 - This transcript has been edited for clarity. Christopher J. Chiu, MD: Welcome back to The Cribsiders. We are the pediatric medicine podcast. From our interviews with leading experts, we bring you clinical pearls and practice-changing knowledge, an...

Abuse of OTC Decongestant Potentially Deadly, FDA Warns
https://www.medscape.com/viewarticle/948125

Mar 25th, 2021 - Abuse or misuse of the over-the-counter (OTC) nasal decongestant propylhexedrine can cause serious harm that can lead to hospitalization, disability, or death, the US Food and Drug Administration (FDA) warns in a safety communication. "Major issue...

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenstone-issues-voluntary-nationwide-recall-diphenoxylate-hydrochloride-and-atropine-sulfate

Summary Company Announcement Date: November 16, 2017 FDA Publish Date: December 29, 2017 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Possible Sub Potent and Super Potent Tablets Company Name: Greenstone LLC, a who...

Fast Five Quiz: Pneumonia Key Aspects
https://reference.medscape.com/viewarticle/922410_2

Mar 23rd, 2020 - Physical examination findings may vary depending on the type of organism, severity of infection, coexisting host factors, and presence of complications. Signs of bacterial pneumonia may include the following: Hyperthermia (fever, typically > 38°C)...

Exercising in Extreme Heat -- How to Avoid Hyperthermia
https://www.medscape.com/viewarticle/916751

Aug 13th, 2019 - Heat stroke is the leading cause of weather-related deaths in the United States, claiming more lives in 2018 than tornadoes and floods combined, according to data from the National Weather Service. And it doesn't discriminate: A professional athle...

see more →